Email Home Page >> Settlements >> Merck, Schering

Merck, Schering Settle Vytorin Zetia Class Action

Merck and Schering Plough have entered into $41.5 million settlement of class action lawsuits related to claims against their shared cholesterol medication Vytorin and Zetia.

The suit revolved around allegations that the results from the Enhance Trial raised questions about the efficacy of the Zetia and Vytorin.

The settlement will resolve approximately 145 lawsuits pending in federal court that seek economic damages related to the purchase of the cholesterol drugs.

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.

Last updated on Aug-5-09